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Summary
 
Bipotent progenitors for T and natural killer (NK) lymphocytes are thought to exist among
early precursor thymocytes. The identification and functional properties of such a progenitor
population remain undefined. We report the identification of a novel developmental stage dur-
ing fetal thymic ontogeny that delineates a population of T/NK-committed progenitors
(NK1.1
 
1
 
/CD117
 
1
 
/CD44
 
1
 
/CD25
 
2
 
). Thymocytes at this stage in development are phenotyp-
ically and functionally distinguishable from the pool of multipotent lymphoid-restricted (B, T,
and NK) precursor thymocytes. Exposure of multipotent precursor thymocytes or fetal liver–
derived hematopoietic progenitors to thymic stroma induces differentiation to the bipotent de-
velopmental stage. Continued exposure to a thymic microenvironment results in predominant
commitment to the T cell lineage, whereas coculture with a bone marrow–derived stromal cell
line results in the generation of mature NK cells. Thus, the restriction point to T and NK lym-
phocyte destinies from a multipotent progenitor stage is marked by a thymus-induced differen-
tiation step.
 
U
 
nderstanding how molecular signals in developing tis-
sues induce commitment and differentiation of stem
cells is a fundamental question of developmental biology.
In the immune system, the thymus provides a model sys-
tem to study the mechanisms controlling tissue-specific dif-
ferentiation events and lineage commitment pathways. During
ontogeny, the thymus is formed when fetal liver–derived
hematopoietic stem cells colonize the rudimentary thymic
stroma at day 12 of fetal life, providing the necessary ele-
ments for the commitment and differentiation of stem cells
into T cells (1–3). Multipotent precursors for T, NK, and B
lymphocyte lineages are present in the early fetal thymus
(1–5); however, it remains unclear when and how commit-
ment and lymphocyte lineage restriction occur. These
newly arrived fetal thymic lymphoid progenitor (TLP)
 
1
 
 cells
display a c-kit
 
1
 
/CD44
 
1
 
/Thy-1
 
lo
 
/CD25
 
2
 
/CD3
 
2
 
/CD4
 
2
 
/
CD8
 
2
 
 cell surface phenotype that is characteristic of he-
matopoietic stem cells (1–5).
Several reports have suggested, but not defined, the pres-
ence of a common thymic progenitor for T and NK lym-
phocytes within the TLP population (6–14). These studies
also failed to address the possibility that NK cells derived
from intravenous injection of immature thymocytes repre-
sent the outgrowth of preexisting cells with a NK pheno-
type within the TLP pool (6–14). To investigate these
questions, we analyzed mouse day 13–15 fetal thymocytes,
which contain precursors for all lymphoid lineages and
have no mature 
 
a
 
/
 
b
 
 T or B lymphocytes (1–5).
We now report the identification of a novel T/NK-
committed progenitor population of early fetal thymocytes
distinguishable from the TLP subset based upon expression
of the natural killer cell marker, NK1.1 (15, 16). Fetal
TLPs lacking NK1.1 (FTLPs) maintain multipotency for
the B, T, and NK lineages, whereas those expressing
NK1.1 (fetal thymic NK1.1
 
1
 
 or FTNK progenitors) are
committed exclusively to T and NK lymphocyte fates, and
have lost B lymphopoietic potential. Furthermore, both
FTLPs and fetal liver–derived hematopoietic precursors
differentiate to the FTNK stage soon after entry into the
thymic microenvironment. Our results identify a novel
stage in fetal thymocyte differentiation that defines an im-
portant restriction point to the T and NK lymphocyte des-
tinies and will facilitate the molecular characterization of
 
1
 
Abbreviations used in this paper:
 
 dGuo, deoxyguanosine; DP, double posi-
tive; FL, fetal liver; FTLP, fetal thymic lymphoid progenitor; FTNK, fetal
thymic NK1.1
 
1
 
; FTOC, fetal thymic organ culture; HSA, heat-stable an-
tigen; SCF, stem cell factor; TLP, thymic lymphoid progenitor.
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thymic stromal signals that are responsible for lineage com-
mitment.
 
Materials and Methods
 
Mice.
 
Timed-pregnant mice, C57Bl/6 and Swiss.NIH, were
obtained from the National Cancer Institute, Frederick Cancer
Research and Development Center (Frederick, MD).
 
Flow Cytometric Analysis and Cell Sorting.
 
Single-cell suspen-
sions were stained for surface expression of various markers using
FITC-, Cychrome-, APC-, PE-, or Red-613–conjugated mAbs
obtained from PharMingen (San Diego, CA) or GIBCO BRL
(Gaithersburg, MD), respectively, in staining buffer HBSS with
1% BSA and 0.05% NaN
 
3
 
). Cells were stained in 100 
 
m
 
l for 30
min on ice and washed twice before analysis. Stained cells were
analyzed with a FACScan
 
Ò
 
 flow cytometer using Lysis II soft-
ware (Becton-Dickinson, Mountain View, CA); data was live-gated
by size and lack of propidium iodide uptake. All plots display
10,000 events contoured at 50% log, except the control panels in
Fig. 2, 
 
b
 
 and 
 
c
 
 where all events (
 
<
 
300 cells) are shown; events
contained in each quadrant are given as percent of total in the up-
per right corner. CD24
 
lo
 
/CD25
 
2
 
 day-14 thymocytes were ob-
tained by antibody- and complement-mediated lysis. Single-cell
suspensions were incubated on ice with 300 
 
m
 
l of culture super-
natant of J11d.2 (anti-CD24) and 7D4 (anti-CD25) for 15 min,
Low-Tox rabbit complement (Cedar Lane, Hornby, ON) was
added at a 1/10 dilution in 3 ml medium, and cells were incu-
bated at 37
 
8
 
C for 30 min. After complement-mediated lysis, viable
cells were recovered by discontinuous density gradient centrifu-
gation with Lympholyte-M (Cedar Lane). CD24
 
lo
 
/CD25
 
2
 
 cells
represented 4% of total day-14 fetal thymocytes, of which 10–20%
show NK1.1
 
1
 
 staining. For cell sorting, fetal thymus single-cell
suspensions were prepared and stained for FACS
 
Ò
 
 as described
above, except that no NaN
 
3
 
 was added to staining buffer. Cells
were sorted using a Coulter Elite cytometer (Hialeah, FL); sorted
cells were 98–99% pure, as determined by post-sort analysis.
Staining with anti-NK1.1 (PK136) was not altered in the pres-
ence of Fc
 
g
 
RII/III blocking antibody (2.4G2), and no significant
staining was observed on immature precursor thymocytes derived
from BALB/c mice, an NK1.1 nonexpressing strain (data not
shown).
 
Fetal Thymic Organ Culture Reconstitution.
 
Sorted populations
were washed twice with DMEM medium supplemented with
12% FCS, 2 mM glutamine, 10 U/ml penicillin, 100 
 
m
 
g/ml
streptomycin, 100 
 
m
 
g/ml gentamicin, 110 
 
m
 
g/ml sodium pyru-
vate, 50 
 
m
 
M 2-mercaptoethanol, and 10 mM Hepes, pH 7.4 (fe-
tal thymic organ culture [FTOC] medium). Day-14 fetal liver
(FL) single-cell suspensions were prepared in the same manner.
Lymphocyte-depleted thymic lobes were prepared by culturing
day-15 fetal thymic lobes from timed-pregnant Swiss mice in
FTOC medium containing 1.35 mM dGuo, as previously de-
scribed (17, 18). In brief, host deoxyguanosine (dGuo)-treated
FTOCs were cultured for 4–6 d, dGuo-containing medium was
replaced with FTOC medium for 1 d, then lobes were rinsed
twice, resuspended in 10 
 
m
 
l medium, and placed in Terasaki
plates at two lobes (one thymus) per well. A titration of 10
 
1
 
–3 
 
3
 
10
 
3
 
 NK1.1
 
2
 
/CD117
 
1
 
 (FTLP), NK1.1
 
1
 
/CD117
 
1
 
 (FTNK), or
1–3 
 
3
 
 10
 
4
 
 FL donor cells were resuspended in 20 
 
m
 
l medium and
added to dGuo-treated alymphoid fetal thymic lobes in Terasaki
plates. After adding donor cells or medium alone, the plates were
inverted (hanging drop) and cultures were incubated at 37
 
8
 
C in a
humidified incubator containing 5% CO
 
2
 
 in air for 24–48 h.
Lobes were then transferred to FTOC for 10–12 d. Cell suspen-
sions from reconstituted thymic lobes were analyzed by flow cy-
tometry. Reconstituted dGuo–FTOC lymphoid cells were 
 
.
 
98%
donor-derived as determined by flow cytometric analysis for do-
nor-specific MHC class I expression. Reconstitution of host
dGuo-treated FTOC was consistently successful only if 
 
.
 
1 
 
3
 
 10
 
3
 
FL donor cells were used, or 
 
.
 
30 FTNK or FTLP donor cells
were used. Cell yields from dGuo–FTOC reconstitution experi-
ments with 0.3–1 
 
3
 
 10
 
3
 
 FTLP or FTNK cells showed no signifi-
cant difference in total thymic cellularity recovered after 12-d
cultures; cell yields for each experiment using 1 
 
3
 
 10
 
3
 
 precursor
FTLP or FTNK cells ranged from 5–15 
 
3
 
 10
 
4
 
 cells/lobe.
 
In Vitro OP9 Stromal Cell Line Coculture.
 
Sorted CD117
 
1
 
/
NK1.1
 
2
 
 FL and fetal thymocytes, FTLP and FTNK, were pre-
pared as described above. A titration of 3 
 
3
 
 10
 
1
 
–4 
 
3
 
 10
 
3
 
 cells
were cocultured in FTOC medium (6-well/plate) for 11 d on a
confluent monolayer of OP9 cells (19, 20) in the presence of IL-3,
IL-6, IL-7, and stem cell factor (SCF) (50 ng/ml of each cyto-
kine), and then stimulated with LPS (10 
 
m
 
g/ml) and IL-7 for 4 d.
Cells and culture supernatant were then harvested for flow cy-
tometry and ELISA analysis, respectively. ELISA analysis (21),
with a sensitivity of 
 
>
 
20 ng/ml of sIgM, revealed the presence of
sIgM from the supernatant of FL and FTLP but not from the
FTNK cocultures. Cell yields from OP9 coculture experiments
with 1–10 
 
3
 
 10
 
2
 
 FTLP or FTNK cells showed a clear difference
in total number of lymphocytes recovered after 7-d cultures, i.e.,
before LPS activation; moreover, cell yields were typically 
 
>
 
100-
fold higher in FTLP/OP9 than in FTNK/OP9 cocultures after
4 d of LPS activation. This increase is due to presence of LPS re-
sponsive B-lineage cells in the FTLP/OP9 cocultures and the
their absence in the FTNK/OP9 cocultures (Fig. 3).
 
Results and Discussion
 
Identification of NK1.1
 
1
 
/CD117
 
1
 
 Cells in the Fetal Thymus.
 
Analysis of mouse day-13–16 fetal thymocytes, showed a
small percentage of NK1.1
 
1
 
 lymphocytes (4–6%) as early as
day 13 of gestation (Fig. 1). We were surprised to detect
NK1.1
 
1
 
 cells in the fetal thymus, because NK1.1
 
1
 
 thy-
mocytes were previously reported to be absent early in thy-
mic ontogeny (6, 13, 14); however, an earlier report by
Koo et al. (22) showed evidence for NK1.1 expression on
early fetal thymocytes. Perhaps, the fact that NK1.1
 
1
 
 cells
represent 
 
<
 
2% of total day-15 fetal thymocytes may ex-
plain why some investigators failed to notice this subset
during thymic ontogeny (6, 13, 14). We further analyzed
fetal thymocytes for expression of the SCF receptor, c-
 
kit
 
(CD117), which is characteristic of hematopoietic precur-
sors in the fetal liver, bone marrow, and thymus (1–3, 14,
23–27). CD117 is expressed on the majority of day 13/14
NK1.1
 
1
 
 thymocytes but on very few NK1.1
 
1
 
 thymocytes
later in ontogeny or in the adult thymus (Fig. 1). Signifi-
cant expression of NK1.1 was not detectable among
CD117
 
1
 
 fetal liver (FL) cells (Fig. 1), suggesting that it may
be induced during or after migration to the thymus.
The most immature progenitor thymocytes are CD117
 
1
 
cells that have not yet expressed the IL-2 receptor 
 
a
 
-chain
(CD25) and bear low levels of Thy-1 (CD90) and heat-sta-
ble antigen (HSA; CD24) (1–3). We purified these progen-
itors by depleting day 14–15 thymocytes of CD25
 
1
 
 and
CD24
 
hi
 
 cells. Within this immature CD90
 
lo
 
/CD24
 
lo
 
/CD25
 
2
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thymocyte pool, NK1.1 expression was evident on a
higher percentage of the cells (10–20%) (Fig. 2 
 
a
 
; data not
shown). Analysis for several other cell surface markers revealed
a composite phenotype that is comparable to that of previ-
ously described early progenitor thymocytes (1–3, 6, 13,
14), demonstrating that this TLP population is not homoge-
nous. Rather, we identify a population with the cell surface
phenotype: NK1.1
 
1
 
/CD117
 
1
 
/CD44
 
1
 
/CD16
 
1
 
/CD32
 
1
 
/
CD90
 
lo
 
/CD24
 
lo
 
/CD252/CD32/CD42/CD82, termed fe-
tal thymic NK1.11 (FTNK) progenitors. These cells dis-
play markers characteristic of thymic progenitor cells as
well as the NK1.1 molecule (NKR–P1C) (15, 16) of NK
cells. A similar finding was recently observed in early im-
mature human thymocytes, in which a small subset of
CD341/CD1171 thymocytes were shown to express a dif-
ferent member of the NKR–P1 gene family, NKR–P1A
(28). Thus, the expression of NKR–P1 genes by early im-
mature thymocytes appears to be a common feature during
mouse and human thymic development.
NK1.11/CD1171 Fetal Thymocytes Serve as Precursors for
Both T and NK Cells. To test whether FTNK progenitors
are indeed a novel population of lymphoid precursor cells,
we isolated FTNK cells from day-14 fetal thymocytes (the
Figure 1. Identification of a novel NK1.11/CD1171 (c-kit) fetal thy-
mocyte population during thymic ontogeny. Two-parameter flow cyto-
metric analysis of cell surface expression of NK1.1 versus CD117 on fetal
thymocytes from timed-pregnant C57BL/6 mice (days 13, 14, 15, 16 of
gestation), fetal liver cells (day 13 of gestation), and thymocytes from adult
mice (8 wk old). NK1.1 and CD117 are coexpressed predominantly early
in thymocyte differentiation.
Figure 2. Sorted NK1.11/
CD1171 (FTNK) fetal thymocytes
give rise to both T and NK lym-
phocytes upon reconstitution of
alymphoid fetal thymic lobes in
vitro. (a) FACSÒ  of CD24lo
(HSA, J11d.2) and CD252 (IL-
2Ra, 7D4) antibody/comple-
ment-depleted day-14 fetal thy-
mocytes from timed-pregnant
mice. Cells were live-gated for
the presence or absence of
NK1.1 and/or CD117; regions
1, 2, and 3 (R1, R2, and R3) in-
dicate the gates used for isolating
either NK1.12/CD1171 (FTLP;
79.4%), NK1.11/CD1171
(FTNK; 8.4%), and NK1.11/
CD1172 (mature NK; 3.4%)
subpopulations, respectively. Two-
parameter analysis of cell surface
expression of b CD4 versus
CD8, and c NK1.1 versus a/b
TCR on thymocytes from
dGuo-treated FTOCs reconsti-
tuted with day-14 fetal liver cells
or sorted day-14 FTLP and
FTNK fetal thymocytes. (b and c)
Panels show dGuo-treated
FTOCs without the addition of
reconstituting cells (Control, first
panel) or with the addition of
day-14 fetal liver (FL, second
panel), FTLP (third panel), or
FTNK (fourth panel) progeni-
tors. The above results are repre-
sentative of at least four indepen-
dent trials. Cell yields for each experiment using 1 3 103 precursor cells ranged from 5–15 3 104 cells/lobe; no significant difference was observed
between FTLP and FTLP reconstituted lobes. Plots display 1 3 104 live-gated events, except in the control panels where all events (<300) are shown.
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population of CD1171, CD90lo, CD24lo, and CD252 cells
that express NK1.1) by antibody- and complement-medi-
ated lysis followed by FACSÒ  (Fig. 2 a, R2 gate; sorted
populations were 98–99% pure; data not shown). FTNK
cells were tested for precursor potential by a 24-h incuba-
tion with host fetal thymic lobes depleted of lymphocytes
with dGuo, followed by FTOC for 10 d (17, 18). Recon-
stituted thymic lobes were analyzed by flow cytometry.
dGuo-depleted FTOCs that were not reconstituted with
precursors remained devoid of T lymphocytes (Fig. 2 b,
Control) (17, 18), whereas nondepleted FTOCs typically
gave rise to both immature CD4/CD8 double-positive
(DP) and mature CD4 and CD8 single-positive (SP) T
lymphocytes (data not shown) (17, 18). dGuo-depleted
thymic lobes reconstituted with FL cells or FTLP cells that
lack NK1.1 expression (FTLPs: NK1.12/CD1171/CD90lo/
CD24lo/CD252 cells; Fig. 2 a, R1 gate) resulted in the
generation of DP and SP T lymphocytes (Fig. 2 b) (4, 5).
Sorted FTNK cells (NK1.11/CD1171/CD90lo/CD24lo/
CD252 cells; Fig. 2 a, R2 gate) also had potent reconstitut-
ing ability, giving rise to DP and mature CD4 and CD8 SP
T lymphocytes (Fig. 2 b). Thus, both FTNK and FTLP
thymocytes display T cell precursor potential. Moreover,
reconstitution experiments revealed that the precursor po-
tential of both populations titrated to a similar dilution
(>30 cells/lobe; data not shown), ruling out the possibility
that a minor admixture of CD1171/NK1.12 cells accounts
for the reconstitution of thymic lobes by FTNK cells. Fur-
thermore, NK1.11 fetal thymocytes lacking CD117 ex-
pression (Fig. 2 a, R3 gate), corresponding to a mature NK
phenotype (Carlyle, J.R., A.M. Michie, and J.C. Zúñiga-
Pflücker, manuscript in preparation), failed to reconstitute
dGuoFTOCs (data not shown), in accord with prior evi-
dence that CD117 expression correlates with precursor ac-
tivity (14, 23–25, 27).
The progeny of FTLP as well as FTNK cells expressed
high levels of a/b T cell receptors and expressed IL-2
mRNA after concanavalin A stimulation, indicating a ma-
ture T cell phenotype (Fig. 2 c; data not shown). Thus, de-
spite bearing the NK1.1 marker, FTNK cells display a cell
surface phenotype similar to TLPs and serve as precursors
to conventional T cells. In addition, both FTLP and FTNK
cells gave rise to NK1.11/TCR2 as well as a few NK1.11/
TCR1 thymocytes, with the former population represent-
ing conventional NK cells and the latter probably correspond-
ing to the recently described CD1-restricted and IL-4–pro-
ducing subset of T cells (29, 30). Thus, FTNK as well as
FTLP thymocytes contain cells with T and NK precursor
potential.
NK1.11/CD1171 Fetal Thymocytes Fail to Serve as Precur-
sors for B-lymphoid or Myeloid Lineage Cells. We and other
investigators have proposed that TLPs display a multipotent
lymphoid precursor potential, which includes the ability to
give rise to T, B, and NK lineages but not to myeloid lin-
eage cells (1–5, 14, 31, 32). We applied an in vitro model
system to test whether the FTLP or FTNK subsets of TLPs
possess B-lymphoid or myeloid differentiation potential.
Sorted CD1171/NK1.12 day-14 FL cells cocultured with
the bone marrow–derived stromal cell line OP9 (19, 20)
predominantly differentiated into functional B cells, as de-
termined by IgM surface expression on B2201 (CD45R)
cells and IgM secretion after induction with LPS and IL-7
(Fig. 3 a; data not shown) (21, 33). FL cells cocultured with
OP9 also gave rise to a myeloid, Mac-11 (CD11b), popu-
lation (Fig. 3 c). A small population of NK1.11 cells was
also detected from FL cells cocultured on OP9 (Fig. 3 b).
Thus, the OP9 cell line supports in vitro B, myeloid, and
NK cell differentiation (19, 20), whereas a/b TCR-bear-
ing T lymphocytes were not detected (Fig. 3; data not
shown).
We next tested the differentiation potential of FTLP
thymocytes after coculture with OP9 cells. As reported for
TLPs in vivo (4, 5, 14, 31, 32), day-14 FTLPs showed a
potent ability to give rise to functional B lymphocytes in
vitro (Fig. 3 a), expressed membrane and secreted IgM, and
gave rise to a small percentage of NK1.11 lymphocytes
(Fig. 3 b). However, unlike FL cells, FTLPs lack myeloid
potential, as demonstrated by their inability to differentiate
into CD11b1 cells (Fig. 3 c). These findings support the
notion that the earliest fetal thymic progenitor population
contains a multipotent lymphoid-restricted precursor (1, 2,
4, 5, 14, 31, 32). However, our failure to detect myeloid
lineage cells derived from day-14 FTLPs is not consistent
Figure 3. Sorted fetal thymic NK1.11/CD1171 (FTNK) progenitors
give rise to NK cells and fail to generate B cells upon OP9 bone marrow
stromal cell line coculture in vitro. Flow cytometric analysis of cell surface
expression of (a) CD45R (B220) versus IgM, (b) NK1.1 versus CD90
(Thy-1), and (c) CD11b (Mac-1) versus forward size scatter (FSC) on
sorted day-14, OP9-cocultured FL, FTLP, and FTNK cells. Cells were
cocultured on confluent OP9 monolayer in the presence of IL-3, IL-6,
IL-7 and SCF for 11 d, then stimulated with LPS and IL-7 for an addi-
tional 4 d before analysis.
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with work from groups that used day-12 fetal thymocytes
as a source of progenitor cells (34, 35). The discrepancy be-
tween these results may be due to the immaturity of the
day-12 fetal thymic microenvironment, as the full capacity
of the fetal thymus to support thymopoiesis does not de-
velop until day 13–14 (36). Restriction of myeloid poten-
tial may be a very rapid event upon entry of a multipotent
precursor into a mature thymic microenvironment, but
may not occur efficiently in the day-12 fetal thymic rudi-
ment.
Both FTLP and FTNK progenitors displayed T and NK
cell lineage precursor potential in FTOC reconstitution as-
says (see Fig. 2, b and c); however, no detectable B cell pre-
cursor potential was evident when FTNK cells were cocul-
tured with OP9, as shown by the lack of CD45R1 cells
expressing surface or secreted forms of IgM (Fig. 3 a; data
not shown). As expected, FTNKs also lacked myeloid po-
tential, as demonstrated by the absence of CD11b1 cells
upon coculture with OP9 cells (Fig. 3 c). Despite the in-
ability of FTNK progenitors to serve as precursors for B
cells after OP9 coculture, these cells showed a strong pre-
cursor potential for NK1.11 lymphocytes (Fig. 3 b). Thus,
the inability to give rise to B cells is not due to an incapac-
ity of FTNK cells to grow on OP9; rather, it demonstrates
a T and NK lineage commitment by FTNK cells, which in
the absence of a proper thymic microenvironment results
in the generation of NK cells (37). Parallel assays in which
sorted FTNK cells were used for both FTOC reconstitu-
tion and OP9 coculture resulted in the generation of T and
NK cells in FTOC, but failed to give rise to B cells in OP9
coculture. Furthermore, the absence of B lymphocytes in
the FTNK/OP9 cocultures, at up to 4,000 cells in culture,
demonstrates that their ability to give rise to T and NK
cells in the thymus does not come from an admixture of
FTLP cells, which are clearly capable of B lymphopoiesis in
OP9 cocultures, with as few as 30 cells in culture (data not
shown). Thus, our results identify a novel population of
CD1171 fetal thymocytes that express the NK1.1 surface
marker and serve as committed bipotent precursors for ma-
ture a/b T lymphocytes and NK cells, whereas CD1171
thymocytes lacking NK1.1 expression can act as multipo-
tent precursors for the T, B, and NK lymphocyte lineages.
NK1.11/CD1171 Fetal Thymocytes Represent an Early De-
velopmental Stage in Thymocyte Differentiation. During early
development, thymic progenitors transiently express vari-
ous markers associated with activated mature T cells (38,
39) and NK cells (6, 13). These include lymphokine recep-
tors such as CD25, several adhesion molecules such as in-
tercellular adhesion molecules, very late activation antigens,
and CD44, and other function-associated molecules such as
CD16/32 (1–3, 6, 38, 39). It would appear that the NK1.11
phenotype also corresponds to a temporary stage that T
lymphocytes pass through on their way to maturity. To test
this, we purified day-14 FTLP and FL cells by FACS Ò  and
followed their developmental progression to determine
whether these isolated precursors could give rise to FTNK
cells in reconstituted dGuo–FTOCs. Indeed, both FL and
FTLP precursors directly give rise to substantial populations
of FTNK cells within 48 h after transfer into FTOCs (Fig.
4). FTLPs appear to differentiate and reach the FTNK stage
with faster kinetics than FL-derived progenitors (Fig. 4).
This finding is in agreement with previous reports showing
that fetal thymus–derived precursors show a faster reconsti-
tution kinetics than FL-derived progenitors (2, 40). The
appearance of FTNK cells peaks by day 4 after thymic re-
constitution with FTLPs (Fig. 4; 83%), and declines by day
6. It is at these later timepoints that FTNK cells gain CD25
expression (Fig. 5 b; 37% of CD1171 gated cells coexpress
NK1.11/CD251), and later lose NK1.1 expression as irre-
Figure 4. Temporal generation of FTNK cells from FTLP and FL pre-
cursors after in vitro transfer into fetal thymi. Sorted (NK1.12/CD1171/
CD90lo/CD24lo/CD252) day-14 fetal thymic lymphoid progenitor
(FTLP) and fetal liver (FL)–derived precursors were transferred into
dGuo-depleted fetal thymic lobes, cultured for 24 h in a hanging drop
configuration, and then cultured in standard FTOC for an additional 1, 3,
or 5 d. Flow cytometric analysis of cell surface expression of NK1.1 versus
CD117 shows that NK1.1 expression is induced on CD1171 precursors
(FTNK stage) as early as 2 d after exposure to thymic stroma, peaks by
day 4, and declines by day 6 with the appearance of NK1.12/CD1172
cells. 3 3 104 sorted cells per dGuo-treated fetal thymus lobe (three
lobes/timepoint) were used; the above results are representative of at least
four independent trials. Cell yields ranged from 1–5 3 103, 0.5–1 3 104,
and 1–3 3 104 cells/lobe at days 2, 4, and 6, respectively. Plots display
1 3 104 live-gated events.
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vocable commitment to the T cell lineage occurs and the
CD251/CD1171/NK1.12 stage is reached (Fig. 5 b) (4, 5).
Again, the temporal kinetics of CD251 expression by
FTNK cells and loss of CD117 expression by developing
thymocytes is more accelerated in dGuo–FTOCs reconsti-
tuted with FTLPs than with FL-derived progenitors (Fig.
5, a and b). Fig. 5 b also shows that by day 6 of reconsti-
tution both precursor cell types give rise to CD1172/
CD252/NK1.11 cells, presumably pre-NK cells, while few
CD1172/CD251/NK1.12 (pre-T cells) are detected. These
cells develop at later timepoints (data not shown). Finally, Fig.
5 b shows that nonreconstituted dGuo–FTOCs (control
FTOC) remain devoid of lymphocytes. Thus, when purified
FTLPs, which make up 4% of total day-14 fetal thymus, or
FL cells are reintroduced to the thymic microenvironment
a synchronized progression through the FTNK stage is clearly
observed (Figs. 4 and 5), which occurs before the CD1171/
CD251 stage of T cell development.
To delineate further this developmental stage, we puri-
fied FTNK progenitors by FACS Ò  and analyzed changes in
their phenotype using defined in vitro culture conditions
that promote commitment to the NK lineage (OP9 cocul-
tures; Fig. 3). Isolated FTNK progenitors cultured in me-
dium containing the cytokines IL-3, IL-6, IL-7, and SCF
to maintain viability (5), retain their phenotype after short-
term (48 h) culture (Fig. 6, Control). In contrast, a similar
Figure 5. Sorted NK1.12/
CD1171 progenitors predomi-
nantly differentiate into T lin-
eage–committed precursors upon
exposure to thymic stroma in vitro.
Three-parameter flow cytomet-
ric analysis of cell surface expres-
sion of CD117, NK1.1, and CD25
on sorted (NK1.12/CD1171/
CD90lo/CD24lo/CD252) day-
14 fetal thymic lymphoid pro-
genitor (FTLP) and fetal liver
(FL)–derived precursor cells.
Panels show relative cell number
(RCN) versus CD117 expression
on total cells, and NK1.1 versus
CD25 expression gated on
CD1171 (R1) and CD1172 (R2)
cell populations, respectively,
from sorted precursors either (a)
before (Control), or (b) 6 d after
transfer into dGuo-depleted fe-
tal thymi (FTOC). Upregula-
tion of CD25 expression, mark-
ing commitment to the T
lineage, occurs on the majority
of NK1.11/CD1171 thymocytes
within 6 d after exposure to thy-
mic stroma.
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exposure of purified FTNKs to the OP9 bone marrow–
derived stromal cell line stimulates commitment to the NK
cell lineage, as indicated by the rapid loss of CD117 expres-
sion with the retention of NK1.1 expression (Fig. 6, OP9).
On the other hand, during reconstitution of dGuo–
FTOCs, not only is CD117 expression retained on FTNK
cells but CD25 expression is induced (see Fig. 5 b). In con-
trast, FTNK cells cultured in isolation or on OP9 cells re-
mained NK1.11 and did not progress to the CD251 stage
of thymocyte development (Fig. 6).
Our findings suggest that the FTNK stage represents a
developmental crossroad during thymocyte differentiation,
where in the thymus most thymocytes will be guided to
enter the T lineage pathway and express CD25 (see Fig. 5),
while a minor fraction will enter the NK lineage, lose
CD117 expression, and fail to express CD25 (Figs. 5 and
6). The generation of small numbers of mature NK cells in
FTOCs (see Fig. 2 c) and during thymic ontogeny in vivo
(see Fig. 1) may result from the occasional or rare failure of
the local thymic microenvironment to support efficiently T
lineage commitment and differentiation. In such instances,
the thymus would still be capable of supporting NK cell
maturation. Stromal influences, thymic or other, appear to
be necessary or at least sufficient for NK cell maturation, as
cells at the bipotent FTNK stage fail to mature into NK
cells when cultured without stromal cells in the presence of
IL-3, IL-6, IL-7, and SCF for up to 8 d in vitro (data not
shown). Cytokines, such as IL-12, IL-15, and perhaps IL-2,
may play a role in the differentiation to the NK lineage
(41–44), while it appears that the cytokines TNF-a and IL-1
are required for T lineage commitment and differentiation
(4). The identification of the FTNK stage of thymocyte
development marks an important step towards the elucida-
tion of the molecular signals responsible for mediating
commitment to T and NK lineages.
Our results demonstrate the existence of a stage in early
thymocyte differentiation during which progenitors tran-
siently express some hallmarks of NK lymphocytes; a stage
that defines commitment towards the T/NK lineages with
the concomitant loss of B lineage potential. Thymocytes at
this stage are phenotypically similar to the TLP population,
but can be distinguished from TLP cells and mature NK
cells based upon expression of NK1.1 and CD117, respec-
tively. Hence, some or all of the previously reported NK
cells derived from intravenous injections of populations of
TLP thymocytes (6, 13, 14) are likely due to the differenti-
ation and outgrowth of the FTNK population or from pre-
existing mature NK cells (Carlyle, J.R., A.M. Michie, and
J.C. Zúñiga-Pflücker, manuscript in preparation). FTNK
cells that retain their NK phenotype but lose CD117 ex-
pression would also lose their ability to differentiate into
T cells and therefore possess an NK-restricted potential.
While this remains to be demonstrated at the clonal level,
we propose that NK1.12 FTLPs represent the earliest thy-
mic progenitors that are multipotent for the B, T, and NK
lineages and rapidly give rise to FTNK precursor cells,
which represent restricted bipotent T/NK precursor cells.
The FTNK stage, as shown in Fig. 7, may represent one
of the earliest phenotypic changes that occurs after hemato-
poietic progenitors enter the thymus. Our data suggests that
the expression of NK1.1 by early precursor thymocytes de-
notes their loss of B cell potential and, therefore, commit-
ment to the T or NK lineages. The stage shown in brackets
represents a transition stage (see Fig. 6; CD1171/NK1.11/
CD251) that would be indicative of precursor thymocytes
progressing to the pro-T cell stage (1–5), but may still dis-
play some NK cell potential (5). Our findings are the first
to delineate and characterize a separate phenotypic stage for
progenitor thymocytes that possess a T/NK-restricted pre-
cursor function, which is distinguishable from the multipo-
tent TLP population and free of preexisting mature NK
cells. Thus, Fig. 7 provides a new paradigm for T cell de-
velopment and defines a novel thymocyte developmental
stage within the full context of thymocyte differentiation.
Figure 6. Sorted NK1.11/
CD1171 (FTNK) progenitors
rapidly differentiate into NK lin-
eage–committed precursors upon
exposure to OP9 bone marrow
stromal cells in vitro. Three-
parameter flow cytometric analy-
sis of cell surface expression of (a)
NK1.1 versus CD25, (b) NK1.1
versus CD117, and (c) CD25 versus
CD117 on sorted, cultured FTNK
progenitors. FTNK progenitors
were generated in vitro as in Fig.
4 (FTLP; day 2); these cells were
then sorted (NK1.11/CD1171/
CD90lo/CD24lo/CD252) and cul-
tured in vitro for an additional
2 d with or without OP9 cells.
Panels show cells cultured in me-
dium plus cytokines (IL-3, IL-6,
IL-7, SCF) alone (Control), or
upon coculture with OP9 bone
marrow stromal cells plus cytokines (OP9). After transfer onto OP9 bone marrow stromal cells, NK1.1 expression is maintained, in the absence of CD25
upregulation, while CD117 expression is rapidly downregulated, marking NK lineage commitment.
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Our findings allow us to redefine which fetal thymocytes
possess a lymphoid-restricted multipotent reconstitution
potential (Fig. 7). In the adult thymus, progenitor cells with
a similar reconstitution potential have been characterized
by their CD441/CD1171/CD4lo phenotype. These CD4lo
precursors have been shown to serve as progenitors for not
only T, NK, and B cells, but also for a novel subset of thy-
mus-derived dendritic cells (1, 31, 32, 45). However, den-
dritic cell potential is not restricted to the CD4lo stage but is
maintained up to the CD441/CD1171/CD251 stage of
thymocyte development (31, 45). Thus, we predict that
FTNK as well as FTLP cells would also serve as progenitors
for thymic dendritic cells, as both the FTNK and FTLP de-
velopmental stages occur before the induction of CD25 ex-
pression (Figs. 5 and 7). Moreover, it appears that the
FTNK stage of thymocyte development is not restricted to
fetal thymocyte development, as FACSÒ -purified CD4lo
progenitor cells from adult mouse thymus also contain a
subset of NK1.11 cells; these cells comprise 4% of CD4lo
progenitors and display a CD441/CD1171/CD4lo/NK1.11
phenotype (data not shown). Thus, the expression of NKR–
P1 genes by early immature thymocytes appears to be a
common feature during both fetal and adult development
in the mouse as well as the human thymus (28).
Taken together, our identification of FTNK cells in the
thymus and the recent description of mature NK1.11 ab T
cells indicate that T and NK lymphocytes may be closely
linked from their earliest differentiation steps and through-
out their maturation. Identification of the restriction point
in which B cell potentiality is lost, whereas that for T or
NK fate is maintained, will facilitate for the molecular
characterization of thymic signals that control this event.
Figure 7. Model of lineage commitment and differentiation events in the mouse fetal thymus. Upon entry into the fetal thymus, multipotent progeni-
tors rapidly commit to the lymphoid lineages (FTLP stage), restricting other hematopoietic potentials including that of the myeloid lineage. Soon after
thymic immigration, a thymus-induced differentiation step marked by expression of NK1.1 (FTNK stage) signifies commitment to the T and NK lin-
eages, with the concomitant loss of B lymphoid potential. FTNK progenitors that undergo a second thymus-induced commitment step, marked by ex-
pression of CD25, lose NK1.1 and commit to the T cell lineage (Pro-T stage). FTNK cells that do not undergo the second thymus-induced differentiation
event lose CD117 expression and become NK lineage–committed precursors (Pre-NK stages).
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